Here at Yorktown Health in Lombard, Illinois, we want you to understand how these medications work and why they might be the right solution for you

Step 4: Schedule Your Consultation Depending on the provider, youll either: Have a live video consultation Complete an asynchronous evaluation (provider reviews and responds) Schedule a phone appointment What to Prepare: List of current medications and supplements Recent blood work results (if available) Questions about side effects, dosing, and expectations Information about any relevant medical conditions Step 5: Get Your Prescription If your provider determines GLP-1s are appropriate, theyll send a prescription to: A partner pharmacy (for compounded medications) Your local pharmacy (for brand-name medications) A mail-order pharmacy (for home delivery) Typical Timeline: Compounded medications: 3-7 days for delivery Brand-name medications: 1-3 days at local pharmacy (if in stock and insurance approves) Step 6: Start Treatment Your provider will typically start you on the lowest dose to minimize side effects: Semaglutide Starting Dose: 0.25 mg weekly for 4 weeks, then increase gradually Tirzepatide Starting Dose: 2.5 mg weekly for 4 weeks, then increase gradually What to Expect: Week 1-4: Side effects most common (usually mild nausea) Week 4-8: Appetite reduction becomes noticeable Week 8-12: Weight loss typically becomes visible (5-10 pounds) Month 3+: Continued steady weight loss (1-2 pounds per week) Step 7: Attend Follow-Up Appointments Regular check-ins allow your provider to: Monitor side effects Adjust dosage as needed Track weight loss progress Modify treatment plan if necessary Most programs schedule monthly follow-ups, though some offer more frequent support

Red Rock Pharmacy stands out by offering two different semaglutide formulations
Our role is to evaluate whether the potential benefit justifies the uncertainty for a given patient, to monitor closely, and to stop if it is not the right fit
doi: 10.2337/ds16-0026
Given the complex and heterogeneous trajectory of FFM during weight regain and considering that FFM is a broader, less metabolically strategic compartment than specific lean mass, as previously discussed, evaluating the qualitative deterioration of muscle tissue emerges as a more critical objective